ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 290 filers reported holding ARGENX SE in Q2 2023. The put-call ratio across all filers is 1.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,877,093 | +66.3% | 81,112 | +31.9% | 0.05% | +70.0% |
| Q2 2023 | $23,973,072 | +33.7% | 61,512 | +27.8% | 0.03% | +20.0% |
| Q1 2023 | $17,927,804 | -37.5% | 48,118 | -36.5% | 0.02% | -43.2% |
| Q4 2022 | $28,696,372 | -99.8% | 75,750 | +62.1% | 0.04% | +69.2% |
| Q3 2022 | $16,499,439,000 | +11701.6% | 46,734 | +12565.0% | 0.03% | – |
| Q2 2022 | $139,807,000 | -73.9% | 369 | -75.8% | 0.00% | -100.0% |
| Q4 2021 | $534,740,000 | -54.9% | 1,527 | -83.0% | 0.00% | -50.0% |
| Q1 2020 | $1,185,570,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |